6520 completed, 2700 unknown, 1426 recruiting, 917 terminated. 2940 Phase 2, 2843 Not applicable, 1912 Phase 1, 1428 Phase 3, 1107 Phase 4.
Follow Liver Diseases: new trials by email Literature Review of Liver Diseases trials Research Report on Liver Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Integrated Care Versus Usual Care for Opioid Use Disorder and Infectious Diseases in Veterans Integrated care - Opioid Use Disorder, HIV | Not applicable | Not yet recruiting | VA Office of Research and Development | 60 | 2028-04-03 | 2026-04-24 |
| National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Evaluating Mesenchymal Stem-Cell (MSC) Therapy in Non-viral Acute on Chronic Liver Failure (ACLF) Patients - Phase-III Trial Umbilical cord Mesenchymal stem cell, Steroid, Standard Medical Treatment - Acute-On-Chronic Liver Failure | Phase 3 | Not yet recruiting | Institute of Liver and Biliary Sciences, India | 100 | 2028-01-01 | 2025-08-17 |
| The Effects of Glucagon on Hepatic Metabolism in People With Type 2 Diabetes After Caloric Restriction Caloric Restriction, Hyperglycemic clamp - Type2diabetes | Phase 2 | Not yet recruiting | Adrian Vella | 20 | 2027-12-15 | 2026-10-28 |
| Liver Steatosis in Pediatric CD Patients Gluten-free diet - Celiac Disease in Children, Non-Alcoholic Fatty Liver Disease | Recruiting | University of Palermo | 91 | 2027-11-01 | 2026-05-01 | |
| Shuganhuazhuo Formula for Advanced Hepatocellular Carcinoma With Damp-Heat Syndrome Shuganhuazhuo Formula, Targeted therapy, Immunotherapy - HCC - Hepatocellular Carcinoma, Chinese Herbal Medicine | Phase 2 | Not yet recruiting | Xiang-Qian | 120 | 2027-09-01 | 2026-08-27 |
| Phase III Clinical Trial of Hepalatide in Patients With Chronic Hepatitis D Hepalatide 2.1mg, Placebo of Hepalatide - Hepatitis D, Chronic | Phase 3 | Not yet recruiting | Shanghai HEP Pharmaceutical Co., Ltd. | 150 | 2027-06-01 | 2026-10-28 |
| SGLT2 Inhibitors as a Novel Treatment for Pediatric Non-Alcoholic Fatty Liver Disease Empagliflozin 10 MG, Placebo Oral Tablet - Non-Alcoholic Fatty Liver Disease, NAFLD | Phase 2 | Not yet recruiting | Justin Ryder | 40 | 2027-05-01 | 2026-01-20 |
| STRIVES: Status-Neutral TeleHealth Concierge Intervention for Unhoused People Who Use Drugs Via Engagement Through Street Medicine Standard of Care (Patient Navigation to Off-Site Clinic), Status-Neutral Telehealth Concierge (SN-THR) - HIV, Substance Use Disorder (SUD) | Not applicable | Not yet recruiting | University of Miami | 200 | 2027-05-01 | 2026-11-12 |
| Liver Transplantation for Non-Resectable Colorectal Liver Metastases Without Local Treatment Options Liver transplantation - Colorectal Neoplasms, Liver Neoplasms | Not applicable | Not yet recruiting | Charite University, Berlin, Germany | 260 | 2027-04-01 | 2026-09-10 |
| Estimating The Rate Of Complete Ablation (A0) With The Use Of Biomechanical Deformable Image Registration RayAblation - Liver Tumors | Not applicable | Not yet recruiting | M.D. Anderson Cancer Center | 200 | 2027-04-01 | 2026-10-16 |
| A Clinical Study Evaluating the Safety and Efficacy of Ivonescimab as Second-line Treatment in Patients With Advanced Hepatocellular Carcinoma Ivonescimab - Hepatocellular Carcinoma (HCC), HCC - Hepatocellular Carcinoma | Phase 2 | Not yet recruiting | MedSIR | 44 | 2027-03-01 | 2026-11-04 |
| Adipose-Derived Mesenchymal Stem Cell for Preventing Biliary Complications Autologous adipose derived mesenchymal stromal cells (AMSC) - Liver Transplant; Complications, Liver Diseases | Phase 1 | Not yet recruiting | Mayo Clinic | 20 | 2027-02-01 | 2026-04-06 |
| Managing Hepatitis B (Hep. B) and Human Papilloma Virus (HPV) Related Cancers and Mental Health. Gardasil 9 vaccine, Hepatitis B Virus Vaccine(HBV), Cognitive Behavioral Therapy - Hepatitis B, Human Papilloma Virus | Phase 4 | Not yet recruiting | Eunice Dube | 2140 | 2027-01-30 | 2026-07-30 |
| Ulonivirine (MK-8507) in Participants With Mild or Moderate Hepatic Impairment (MK-8507-014) Ulonivirine - Hepatic Insufficiency | Phase 1 | Not yet recruiting | Merck Sharp & Dohme LLC | 22 | 2027-01-22 | 2026-07-16 |
| Combating Related Epidemics in HCV Cepheid GeneXpert HCV Test, INSTI HIV - 1/2 Antibody, bioLytical Laboratories iStatis Hepatitis B Surface Antigen Test - HIV - Human Immunodeficiency Virus, Hepatitis B Virus (HBV) | Phase 4 | Not yet recruiting | Duke University | 1280 | 2027-01-20 | 2026-11-18 |
| A Phase 1 Clinical Trial of Adjuvanted Protein-based HCV Vaccine Candidates (HCV Vaccine Trial) AVIHepC1, Normal Saline - Hepatitis C | Phase 1 | Not yet recruiting | University of Alberta | 27 | 2027-01-15 | 2026-09-25 |
| Liver Micro Flow - MRI Novel MRI Software, Ensure Plus Nutrition Shake - Liver Diseases | Not yet recruiting | University of Wisconsin, Madison | 110 | 2027-01-15 | 2026-09-29 | |
| Blood Flow Restriction Training After TIPS Placement in Liver Cirrhosis Blood-flow restriction training (BFRT) - Liver Cirrhosis, TIPS Insertion | Not applicable | Not yet recruiting | German Diabetes Center | 30 | 2027-01-02 | 2026-11-13 |
| Human Models of Selective Insulin Resistance: Pancreatic Clamp Insulin human, Octreotide Acetate, Glucagon - Insulin Resistance, Hyperinsulinemia | Phase 1 | Not yet recruiting | Columbia University | 36 | 2027-01-01 | 2026-02-06 |
| NK521 in the Treatment of Advanced Solid Tumors NK521 Cell Injection - Hepatocellular Carcinoma (HCC), Ovarian Cancer | Early Phase 1 | Not yet recruiting | Base Therapeutics (Shanghai) Co., Ltd. | 18 | 2027-01-01 | 2026-09-30 |
Showing 20 of 13225. Sign in to see all of them.
Carcinoma, Hepatocellular (3390) · Hepatitis C (1722) · Non-alcoholic Fatty Liver Disease (1602) · Liver Neoplasms (1296) · Liver Cirrhosis (1273) · Hepatitis B (1007) · Hepatitis C, Chronic (907) · Hepatitis B, Chronic (869) · Fibrosis (679) · Fatty Liver (600) · Hypertension, Portal (365) · Obesity (322) · Hepatitis (321) · Pancreatic Neoplasms (284)
Digestive System Diseases (13149) · Pathological Conditions, Signs and Symptoms (5045) · Pathologic Processes (4562) · Infections (4301) · Neoplasms by Site (4208) · Virus Diseases (4168) · Digestive System Neoplasms (4163) · Hepatitis (4126) · Neoplasms (4046) · Hepatitis, Viral, Human (4027) · Blood-Borne Infections (3974) · Communicable Diseases (3961) · Neoplasms by Histologic Type (3603) · Neoplasms, Glandular and Epithelial (3515)
Ribavirin (673) · peginterferon alfa-2a (426) · Sorafenib (243) · entecavir (206) · Tenofovir (195) · Sofosbuvir (183) · peginterferon alfa-2b (182) · lenvatinib (161) · Bevacizumab (155) · Blood Specimen Collection (106) · Nivolumab (102) · daclatasvir (101) · atezolizumab (89) · Radiosurgery (86) · pembrolizumab (84)
GlaxoSmithKline (223) · Merck Sharp & Dohme LLC (213) · Gilead Sciences (201) · Sun Yat-sen University (201) · Bristol-Myers Squibb (164) · Hoffmann-La Roche (164) · Institute of Liver and Biliary Sciences, India (149) · Assiut University (136) · National Taiwan University Hospital (123) · National Cancer Institute (NCI) (102) · AbbVie (101) · Shanghai Zhongshan Hospital (101) · Assistance Publique - Hôpitaux de Paris (98) · Seoul National University Hospital (93) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (84)
United States (3786) · China (2543) · France (1027) · Germany (780) · United Kingdom (739) · Canada (730) · South Korea (730) · Italy (692) · Spain (684) · Taiwan (634) · Australia (453) · Belgium (452) · India (349) · Egypt (341) · Hong Kong (313)
Ming Shi, MD (21)
PMID 37467180, PMID 30739368, PMID 30977945, PMID 12049862, PMID 30012435, PMID 30923816, PMID 28193518, PMID 29461687, PMID 31568620, PMID 11981766, PMID 19192962, PMID 28427875, PMID 30529905, PMID 36318027, PMID 12540794, PMID 18650514, PMID 29377566, PMID 29404492, PMID 29628281, PMID 40434633, PMID 19052126, PMID 19095497, PMID 23607594, PMID 25445400, PMID 26047908, PMID 28404091, PMID 28404092, PMID 30868245, PMID 32402160, PMID 32710245, PMID 34143971, PMID 34256305, PMID 36852452, PMID 37183883, PMID 37786277, PMID 41586499, PMID 12091661, PMID 21374666, PMID 24209977, PMID 24915612, PMID 25040192, PMID 25543678, PMID 25583164, PMID 26575258, PMID 26683763, PMID 26707365, PMID 27847279, PMID 27932229, PMID 29405329, PMID 29433850
2016 (63), 2014 (58), 2015 (56), 2019 (51), 2023 (43), 2009 (38), 2017 (36), 2018 (31), 2025 (24), 2008 (20), 2004 (13), P30CA016672 (12), 2005 (11), P30CA060553 (10), P30CA015083 (8)